Searchable abstracts of presentations at key conferences in endocrinology

ea0035p403 | Diabetes complications | ECE2014

Does proton pump inhibitor use decrease microvascular complicaton rate in type 2 diabetic patients? A retrospective analysis

Kut Altug , Bozkus Yusuf , Anil Cuneyd , Tutuncu Neslihan Bascil

Proton pump inhibitor (PPI) drugs which are used safely to treat peptic ulcus disease since 2 decades, moderately increases gastrin hormone by decreasing gastric acid secretion. Preclinical studies show that gastrin itself, or drugs that increase gastrin levels such as PPIs, increase islet cell mass and improve glycaemic control. To the best of our knowledge one prospective and some retrospective studies claim that PPI medication in diabetic patients leads to an average decrea...

ea0035p469 | Diabetes therapy | ECE2014

Effect of angiotensin receptor blockers on glycaemic control in type 2 diabetic patients? A retrospective analysis

Bozkus Yusuf , Kut Altug , Kirnap Nazli , Tutuncu Neslihan Bascil

Experimental and clinical studies suggest that blocking the effects of angiotensin II increases insulin sensitivity, skeletal muscle glucose transport, and pancreatic blood flow which may contribute to the prevention of diabetes mellitus. Although large scale studies and meta-analysis reveal that the new onset of diabetes could be significantly decreased by ARBs in both hypertensive and normotensive patients, their effect on glucose regulation in patients already diagnosed wit...

ea0035p470 | Diabetes therapy | ECE2014

Comparison of angiotensin receptor blockers and angiotensin converting enzyme inhibitors for glycaemic regulation

Kut Altug , Bozkus Yusuf , Firat Sevde Nur , Tutuncu Neslihan Bascil

Large scale clinical studies and meta-analysis suggest that treatment with angiotensin receptor blockers (ARBs) and angiotensin converting enzyme inhibitors (ACEIs) could have protective effect against diabetes development. While diuretics and β-blockers have some well known adverse effect on glycaemic regulation, ARBs/ACEIs’ effect on glucose regulation in patients already diagnosed with diabetes has not been investigated well enough. Also to the best of our knowled...

ea0022p467 | Female reproduction | ECE2010

Serum lipocalin-2 as an insulin resistance marker in patients with polycystic ovary syndrome

Cakal Erman , Ozkaya Mesut , Engin-Ustun Yaprak , Ustun Yusuf

Background: Our aim was to investigate levels of lipocalin-2 and its relationship with metabolic factors in women with polycystic ovary syndrome (PCOS).Materials/subjects and methods: In this cross-sectional study, two groups of women were studied: group 1 consisted of women with PCOS (n=30), and group 2 consisted of control women with normal ovulatory function (n=30). The circulating levels of lipocalin were measured.<p class="abstext"...

ea0020p473 | Obesity and Metabolism | ECE2009

Association between platelet count and metabolic risk factors in over weight and obese women

Kutluturk Faruk , Tanyolac Sinan , Azezli Adil , Orhan Yusuf

Introduction: We aimed to evaluate the relationship between platelet count and metabolic risk factors in over weight and obese women in Turkish women.Methods: Over weight (BMI>25 kg/m2) 665 and obese (BMI>30 kg/m2) 4609 women were enrolled into the study. The patients were divided into three group according to the platelet count (PLT), Group I (n=1724) consist of serum PLT≤245×103, group II (n...

ea0020p478 | Obesity and Metabolism | ECE2009

Relationship between prehypertension and metabolic risk markers in over weight and obese women

Kutluturk Faruk , Bayraktaroglu Taner , Azezli Adil , Orhan Yusuf

Introduction: Hypertension is a major risk factor for several cardiovascular diseases including coronary heart disease. Prehypertension is defined systolic blood pressure (SBP) between 120–139 mmHg and diastolic blood pressure (DBP) 80–89 mmHg. Recent studies have documented an increased risk of cardiovascular disease in persons with prehypertension. In this study, we evaluated association between prehypertension and the metabolic risk markers in over weight and obes...

ea0016p245 | Diabetes and cardiovascular diseases | ECE2008

Correlation between inflammation markers and plasma fasting glucose in overweight and obese women

Kutluturk Faruk , Bayraktaroglu Taner , Azezli Adil , Orhan Yusuf

Introduction: Elevated levels of the inflammatory markers are associated with increased risk for CVD and diabetes mellitus. There is accumulating evidence indicating that inflammatory markers as C-reactive protein (CRP) is associated with insulin resistance. The aim of the study is to evaluate the correlations between serum inflammatory markers and plasma fasting glucose (PFG) in overweight and obese women.Methods: Overweight (25<BMI<30 kg/m...

ea0016p363 | Growth factors | ECE2008

Does administration of octreotide acetate prevent development of diabetic nephropathy? an ultrastructural evaluation of the effects of octreotide acetate on kidney tisssue in Streptozotocin induced diabetic rats

Bahceci Selen , Nergiz Yusuf , Bahceci Mithat , Akkus Murat

Background and aims: Growth hormone and insulin-like growth factors to be involved in the pathogenesis of diabetic kidney disease. The aim of this study was ultrastructural evaluation of octreotide acetate on kidney tissue in streptozotocin (STZ) induced diabetic rats.Material and methods: Twenty-four male Spraque–Dawley rats divided into 3 groups; control (C), diabetic (D) and diabetic with octreotide aceatate (DO). The all diabetic rats were treat...

ea0016p518 | Obesity | ECE2008

Glomerular filtration rates as a cardiometabolic risk markers in obese women

Bayraktaroglu Taner , Kutluturk Faruk , Dogan Azezli Adil , Orhan Yusuf

Introduction: This study carried out relationship between glomerulary filtration rates (GFR) and various metabolic parameters in obese women.Materials and methods: Selected subjects recruited retrospectively from outpatient clinic for this study were 5115 overweight or obese women with mean GFR which was 93 ml/dk/1.73 m2 calculated by MDRD (modification of diet in renal disease). According to mean GFR, they divided group I (low GFR) having &#8...

ea0016p559 | Obesity | ECE2008

Relation of high-sensitive C-reactive protein and metabolic risk factors in overweight and obese women

Kutluturk Faruk , Bayraktaroglu Taner , Azezli Adil , Orhan Yusuf

Introduction: Elevated high-sensitive c-reactive protein (hs-CRP) in association with hyperinsulinemia, obesity, insulin resistance and high blood pressure are significant risk factors for cardiovascular diseases. The aim of this study is to evaluated the correlations between serum hs-CRP concentration and metabolic risk factors in overweight and obese women.Methods: Overweight (BMI>25 kg/m2) and obese (BMI>30 kg/m2) 755 wom...